Show
Sort by
-
Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis
-
Galactose modified iNKT cell agonists stabilised by a novel structural modification of CD1D lead to marked TH1 polarisation in vivo
-
Invariant natural killer T cells are natural regulators of murine spondylarthritis
-
Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid
-
Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis
-
Cutting Edge: The Chemokine Receptor CXCR3 Retains Invariant NK T Cells in the Thymus